FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor

Oncogene

Volumn 23, Issue 32, 2004, Pages 5435-5446

  Ramirez Montagut, Teresa ^a   Blachere, Nathalie E ^b   Sviderskaya, Elena V ^c   Bennett, Dorothy C ^c   Rettig, Wolfgang J ^d   Garin Chesa, Pilar ^e   Houghton, Alan N ^a  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

Fibroblast activation protein ; Melanoma; Peptidase; Tumor suppressor; Wound healing

Indexed keywords

CASPASE; DIPEPTIDYL PEPTIDASE IV; MUTANT PROTEIN; RAG1 PROTEIN; SEPRASE; SERINE PROTEINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; GELATINASE; MEMBRANE PROTEIN; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL SURVIVAL; CONTACT INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; MELANOMA CELL; MITOSIS INHIBITION; MOLECULAR CLONING; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; TUMOR REJECTION; WOUND HEALING; ANIMAL; CELL CYCLE; GENETIC TRANSFECTION; GENETICS; MELANOCYTE; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALIA;

ANIMALS; ANTIGENS, CD26; APOPTOSIS; CELL CYCLE; CONTACT INHIBITION; GELATINASES; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; MICE; MUTATION; SERINE; SERINE ENDOPEPTIDASES; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 3843069939     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207730     Document Type: Article

References (23)

1. Bennett DC, Cooper PJ and Hart IR. (1987). Int. J. Cancer, 39, 414-418.
2. Berkelhammer J, Oxenhandler RW, Hook Jr RR and Hennessy JM. (1982). Cancer Res., 42, 3157-3163.
3. Brown DD, Wang Z, Furlow JD, Kanamori A, Schwartzman RA, Remo BF and Finder A. (1996). Proc. Natl. Acad. Sci. USA, 93, 1924-1929.
4. Cheng JD, Dunbrack Jr RL, Valianou M, Rogatko A, Alpaugh RK and Weiner LM. (2002). Cancer Res., 62, 4767-4772.
5. Desmouliere A. (1995). Cell Biol. Int., 19, 471-476.
6. Garin-Chesa P, Old LJ and Rettig WJ. (1990). Proc. Natl. Acad. Sci. USA, 87, 7235-7239.
7. Hearing VJ, Cannon GB, Vieira WD, Jimenez-Atienzar M, Kameyama K and Law LW. (1988). Int. J. Cancer, 41, 275-282.
8. Hearing VJ, Vieira WD and Law LW. (1985). Int. J. Cancer, 35, 403-409.
9. Hofmann UB, Westphal JR, Van Muijen GN and Ruiter DJ. (2000). J. Invest. Dermatol., 115, 337-344.
10. Houghton AN, Albino AP, Cordon-Cardo C, Davis LJ and Eisinger M. (1988). J. Exp. Med., 167, 197-212.
11. Houghton AN, Real FX, Davis LJ, Cordon-Cardo C and Old LJ. (1987). J. Exp. Med., 165, 812-829.
12. Huber MA, Kraut N, Park JE, Schubert RD, Rettig WJ, Peter RU and Garin-Chesa P. (2003). J. Invest. Dermatol., 120, 182-188.
13. Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP and Houghton AN. (1993). J. Exp. Med., 111, 1135-1143.
14. Niedermeyer J, Garin-Chesa P, Kriz M, Hilberg F, Mueller E, Bamberger U, Rettig WJ and Schnapp A. (2001). Int. J. Dev. Biol., 45, 445-447.
15. Niedermeyer J, Scanlan MJ, Garin-Chesa P, Daiber C, Fiebig HH, Old LJ, Rettig WJ and Schnapp A. (1997). Int. J. Cancer, 71, 383-389.
16. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ and Rettig WJ. (1999). J. Biol. Chem., 274, 36505-36512.
17. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Ozer HL, Schwab M, Albino AP and Old LJ. (1993). Cancer Res., 53, 3327-3335.
18. Rettig WJ, Su SL, Fortunato SR, Scanlan MJ, Raj BK, Garin-Chesa P, Healey JH and Old LJ. (1994). Int. J. Cancer, 58, 385-392.
19. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ and Rettig WJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 5657-5661.
20. Sviderskaya EV, Wakeling WF and Bennett DC. (1995). Development, 121, 1547-1557.
21. Tsujimoto H, Nishizuka S, Redpath JL and Stanbridge EJ. (1999). Mol. Carcinogen., 26, 298-304.
22. Tuxhorn JA, Ayala GE and Rowley DR. (2001). J. Urol., 166, 2472-2483.
23. Wesley UV, Albino AP, Tiwari S and Houghton AN. (1999). J. Exp. Med., 190, 311-322.